Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Examining the relationship between oral and intestinal bacteria in patients with a specific gum disease

Official title: Characterization of Peroodontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid: a Matched Controlled Study

Run by Centre Hospitalier Universitaire de Nice · NCT06291350 · Data updated 2026-11-12

This study is trying to see how the bacteria in the mouth and gut affect people with a specific gum disease called Mucous Membrane Pemphigoid and whether these bacteria make their gum problems worse.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Locations3 sites (Nice and 2 other locations)
StatusRecruiting
StartedOctober 24, 2024
Main results expectedJune 15, 2026
Study endsNovember 15, 2026
Registry record updatedMarch 20, 2025
Trial IDNCT06291350 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with MMPg and associated periodontal issues, as well as matched controls with periodontitis or healthy periodontal conditions.

Probably not a fit

Patients currently undergoing antibiotic therapy or mechanical periodontal treatment, or those with other chronic immune or digestive illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the periodontal and intestinal microbiota in patients diagnosed with Mucous Membrane Pemphigoid (MMPg) who also experience desquamative gingivitis. The research aims to understand how the dysbiotic oral microbiota may worsen gingival damage and whether the autoimmune process in MMPg affects the virulence of periodontal pathogens. Participants will undergo plaque sampling, stool collection, and periodontal examinations to assess their conditions and microbiota profiles. The study includes adults over 18 years, focusing on those with varying degrees of periodontal health and MMPg.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of periodontal disease in patients with autoimmune conditions.

How similar studies have gone: While the relationship between oral and intestinal microbiota has been explored, this specific approach in the context of MMPg is relatively novel and not extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults (over 18), non-smokers Arm 1

* MMPg (initial, persistent despite medical treatment, recurrent), periodontitis Arm 2
* non-MMPg, periodontitis, matched to cases on age, gender and severity of periodontitis

Arm 3:

\- non-MMPg, healthy periodontal conditions, matched to cases on age and gender

Exclusion Criteria:

* Antibiotic therapy and mechanical periodontal treatment within 3 months prior to study, other chronic general illness of immune or digestive origin

Where it's running

  • Nice University Hospital
    Nice, France
    Recruiting
  • Paris hospital Pitié Salpetrière (APHP)
    Paris, France
    Recruiting
  • Paris hospital Bretonneau (APHP)
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.